Anti-LXR alpha antibody [EPR6508(N)] - BSA and Azide free
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(1 Publication)
Rabbit Recombinant Monoclonal LXR alpha antibody. Carrier free. Suitable for WB and reacts with Human, Transfected cell line - Human samples. Cited in 1 publication.
View Alternative Names
LXRA, NR1H3, Oxysterols receptor LXR-alpha, Liver X receptor alpha, Nuclear receptor subfamily 1 group H member 3
- WB
Lab
Western blot - Anti-LXR alpha antibody [EPR6508(N)] - BSA and Azide free (AB190727)
Blocking buffer and concentration : 5% NFDM/TBST Diluting buffer and concentration : 5% NFDM/TBST ab176323 does not cross activate with human LXR beta. ab213204 was used as loading control. This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab176323).
All lanes:
Western blot - Anti-LXR alpha antibody [EPR6508(N)] (<a href='/en-us/products/primary-antibodies/lxr-alpha-antibody-epr6508n-ab176323'>ab176323</a>) at 1/1000 dilution
Lane 1:
HEK 293 transfected with blank vectors, whole cell lysate at 20 µg
Lane 2:
HEK 293 transfected with His tagged human LXR alpha full length expression vectors, whole cell lysate at 20 µg
Lane 3:
HEK 293 transfected with His tagged human LXR beta full length expression vectors, whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 50 kDa
Observed band size: 50 kDa
false
Exposure time: 3s
- WB
Lab
Western blot - Anti-LXR alpha antibody [EPR6508(N)] - BSA and Azide free (AB190727)
Blocking buffer and concentration : 5% NFDM/TBST Diluting buffer and concentration : 5% NFDM/TBST ab176323 detects a higher band in nuclear fraction than in non-nuclear fraction, which might be the correct band of interest. ab176842 and ab181602 were used as loading controls. This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab176323).
All lanes:
Western blot - Anti-LXR alpha antibody [EPR6508(N)] (<a href='/en-us/products/primary-antibodies/lxr-alpha-antibody-epr6508n-ab176323'>ab176323</a>) at 1/1000 dilution
Lane 1:
Jurkat (Human T cell leukemia T lymphocyte) cells non-nuclear fraction at 20 µg
Lane 2:
Jurkat (Human T cell leukemia T lymphocyte) cells nuclear fraction at 20 µg
Lane 3:
SH-SY5Y (Human neuroblastoma epithelial cell) cells non-nuclear fraction at 20 µg
Lane 4:
SH-SY5Y (Human neuroblastoma epithelial cell) cells nuclear fraction at 20 µg
Lane 5:
IMR-32 (Human neuroblastoma neuroblast) cells non-nuclear fraction at 20 µg
Lane 6:
IMR-32 (Human neuroblastoma neuroblast) cells nuclear fraction at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 50 kDa
Observed band size: 50 kDa
false
Exposure time: 7s
- WB
Lab
Western blot - Anti-LXR alpha antibody [EPR6508(N)] - BSA and Azide free (AB190727)
Blocking buffer and concentration : 5% NFDM/TBST Diluting buffer and concentration : 5% NFDM/TBST ab176323 detects a higher band in nuclear fraction than in non-nuclear fraction, which might be the correct band of interest. ab213204, ab176842 and ab181602 were used as loading controls. This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab176323).
All lanes:
Western blot - Anti-LXR alpha antibody [EPR6508(N)] (<a href='/en-us/products/primary-antibodies/lxr-alpha-antibody-epr6508n-ab176323'>ab176323</a>) at 1/1000 dilution
Lane 1:
HEK 293 transfected with blank vectors, whole cell lysate at 20 µg
Lane 2:
HEK 293 transfected with blank vectors, non-nuclear fraction at 20 µg
Lane 3:
HEK 293 transfected with blank vectors, nuclear fraction at 20 µg
Lane 4:
HEK 293 transfected with His tagged human LXR alpha full length expression vectors, non-nuclear fraction at 20 µg
Lane 5:
HEK 293 transfected with His tagged human LXR alpha full length expression vectors, nuclear fraction at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 50 kDa
Observed band size: 50 kDa
false
Exposure time: 10s
Related conjugates and formulations (2)
-
Anti-LXR alpha antibody [EPR6508(N)]
-
HRP Anti-LXR alpha antibody [EPR6508(N)]
Reactivity data
Product details
ab190727 is the carrier-free version of ab176323.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
LXR alpha plays a critical role in lipid metabolism and cholesterol efflux. It is part of a larger LXR and CO complex which contributes to the regulation of genes that manage cholesterol absorption transport and excretion. For instance LXR activation increases the expression of ATP-binding cassette transporters such as ABCA1 and ABCG1 which are essential for transporting cholesterol out of cells and facilitating reverse cholesterol transport.
Pathways
The function of LXR alpha is significant in both the cholesterol catabolism pathway and the inflammatory response pathway. Within these pathways it upregulates genes involved in cholesterol catabolism providing a mechanism to prevent excess accumulation in cells and tissues. LXR alpha interacts closely with other nuclear receptors and proteins like PPARs (peroxisome proliferator-activated receptors) highlighting its role in lipid signaling networks.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
Oncogenesis 10:13 PubMed33568624
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com